Abstract

BackgroundMyocardial infarction (MI) is a multifactorial disease with complex pathogenesis, mainly the result of the interplay of genetic and environmental risk factors. The regulation of thrombosis, inflammation and cholesterol and lipid metabolism are the main factors that have been proposed thus far to be involved in the pathogenesis of MI. Traditional risk-estimation tools depend largely on conventional risk factors but there is a need for identification of novel biochemical and genetic markers. The aim of the study is to identify differentially expressed genes that are consistently associated with the incidence myocardial infarction (MI), which could be potentially incorporated into the traditional cardiovascular diseases risk factors models.MethodsThe biomedical literature and gene expression databases, PubMed and GEO, respectively, were searched following the PRISMA guidelines. The key inclusion criteria were gene expression data derived from case-control studies on MI patients from blood samples. Gene expression datasets regarding the effect of medicinal drugs on MI were excluded. The t-test was applied to gene expression data from case-control studies in MI patients.ResultsA total of 162 articles and 174 gene expression datasets were retrieved. Of those a total of 4 gene expression datasets met the inclusion criteria, which contained data on 31,180 loci in 93 MI patients and 89 healthy individuals. Collectively, 626 differentially expressed genes were detected in MI patients as compared to non-affected individuals at an FDR q-value = 0.01. Of those, 88 genes/gene products were interconnected in an interaction network. Totally, 15 genes were identified as hubs of the network.ConclusionsFunctional enrichment analyses revealed that the DEGs and that they are mainly involved in inflammatory/wound healing, RNA processing/transport mechanisms and a yet not fully characterized pathway implicated in RNA transport and nuclear pore proteins. The overlap between the DEGs identified in this study and the genes identified through genetic-association studies is minimal. These data could be useful in future studies on the molecular mechanisms of MI as well as diagnostic and prognostic markers.

Highlights

  • Myocardial infarction (MI) is a multifactorial disease with complex pathogenesis, mainly the result of the interplay of genetic and environmental risk factors

  • The molecular mechanisms that have been proposed far to underlie the pathogenesis of myocardial infarction (MI), apart from those related to cholesterol and lipid metabolism, include mechanisms related to the regulation of thrombosis and inflammation [8,9,10]

  • The paper published by Głogowska-Ligus and Dąbek (2012) [42] did not make the data available, but the authors identified 26 differentially expressed genes (DEGs) (Additional file 1: Table S1)

Read more

Summary

Introduction

Myocardial infarction (MI) is a multifactorial disease with complex pathogenesis, mainly the result of the interplay of genetic and environmental risk factors. The regulation of thrombosis, inflammation and cholesterol and lipid metabolism are the main factors that have been proposed far to be involved in the pathogenesis of MI. Atherosclerotic heart disease is manifested by atherosclerosis and has a broad underlying pathophysiological spectrum. It comprises, among others, ischemic heart disease (IHD), coronary artery disease (CAD), stroke, and myocardial infarction (MI), commonly known as heart attack. The molecular mechanisms that have been proposed far to underlie the pathogenesis of MI, apart from those related to cholesterol and lipid metabolism, include mechanisms related to the regulation of thrombosis and inflammation [8,9,10]. Emerging roles have been attributed to oxidative stress and DNA damage [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call